Track Genetic Technologies's current cash ($1M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Genetic Technologies (GENE) currently reports a current cash of $1M as of June 2024. That compares with $7.9M in the prior-year period — down 87.0% year over year. Use the charts on this page to explore Genetic Technologies's current cash history and peer comparisons.
Genetic Technologies's current cash decreased from $7.9M to $1M — a 87.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Genetic Technologies reported $1M in current cash as of June 2024. That compares with $7.9M in the prior-year period — down 87.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genetic Technologies, and consider following GENE for alerts when major investors trade the stock.
Genetic Technologies is classified in the Healthcare sector. On current cash, it currently shows $1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GENE with unrelated industries.